Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study).
Sepe P, Procopio G, Pircher CC, Basso U, Caffo O, Cappelletti V, Claps M, De Giorgi U, Fratino L, Guadalupi V, Miodini P, De Marco C, Perrucci B, Mennitto A, Santini D, Spina F, Stellato M, de Braud F, Verzoni E. Sepe P, et al. Among authors: guadalupi v. Ther Adv Med Oncol. 2024 Jan 22;16:17588359231217958. doi: 10.1177/17588359231217958. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38264520 Free PMC article.
Activity of sunitinib in patients with advanced neuroendocrine tumors.
Bajetta E, Guadalupi V, Procopio G. Bajetta E, et al. Among authors: guadalupi v. J Clin Oncol. 2009 Jan 10;27(2):319-20; author reply 320. doi: 10.1200/JCO.2008.20.3034. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064950 No abstract available.
Current Understanding of Urachal Adenocarcinoma and Management Strategy.
Claps M, Stellato M, Zattarin E, Mennitto A, Sepe P, Guadalupi V, Mennitto R, de Braud FGM, Verzoni E, Procopio G. Claps M, et al. Among authors: guadalupi v. Curr Oncol Rep. 2020 Jan 27;22(1):9. doi: 10.1007/s11912-020-0878-z. Curr Oncol Rep. 2020. PMID: 31989430 Review.
The emerging role of PARP inhibitors in prostate cancer.
Stellato M, Guadalupi V, Sepe P, Mennitto A, Claps M, Zattarin E, Verzoni E, Valdagni R, De Braud FG, Santini D, Tonini G, Procopio G. Stellato M, et al. Among authors: guadalupi v. Expert Rev Anticancer Ther. 2020 Aug;20(8):715-726. doi: 10.1080/14737140.2020.1797497. Epub 2020 Aug 6. Expert Rev Anticancer Ther. 2020. PMID: 32758032 Review.
36 results